Dual Inhibitors Targeting DNA and Histone Deacetylases
Histone deacetylases (HDACs) regulate the acetylation status of histones and structural status of chromatin. The chromatin structure becomes relaxed after inhibition of HDAC, leading to DNA exposed to DNA disrupting agents, and eventually causing DNA dysfunction. Recently, more and more dual inhibit...
Furkejuvvon:
Váldodahkkit: | Chen Chen (Dahkki), Xinying Yang (Dahkki), Xuben Hou (Dahkki), Hao Fang (Dahkki) |
---|---|
Materiálatiipa: | Girji |
Almmustuhtton: |
Georg Thieme Verlag KG,
2020-06-01T00:00:00Z.
|
Fáttát: | |
Liŋkkat: | Connect to this object online. |
Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Geahča maid
-
Targeting histone deacetylases for cancer therapy: Trends and challenges
Dahkki: Tao Liang, et al.
Almmustuhtton: (2023) -
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
Dahkki: Milan Beljkas, et al.
Almmustuhtton: (2023) -
Histone deacetylase inhibitors
Dahkki: Marzena Baran, et al.
Almmustuhtton: (2020) -
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
Dahkki: Fabian B. Kraft, et al.
Almmustuhtton: (2023) -
Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
Dahkki: Danqi Chen, et al.
Almmustuhtton: (2016)